The efficacy of topically applied curcumin 1% as alternative or complementary to triamcinolone acetonate in treatment of oral lichen planus (randomized control trial)

Abstract Background Oral lichen planus (OLP) is a chronic inflammatory disorder affecting the mucous membranes, believed to be an immune-mediated condition. Its persisting nature can lead to extended discomfort for those affected. The primary symptoms are pain and a burning sensation, with a potential risk of malignancy if not properly managed, necessitating lifelong clinical monitoring. Presently, OLP is considered a significant challenge due to the absence of a definitive cure. Patients and methods Thirty patients with OLP were divided into three groups, 10 patients each: group A: 10 patients with OLP were received topical triamcinolone acetonide. Group B: 10 patients with OLP were received topical curcumin. Group C: 10 patients with OLP were received topical triamcinolone acetonide combined with topical curcumin for 6 weeks. Each patient was examined at baseline, 1 and 3 months of therapy. Pain was scored using the visual analog scale. Salivary level of interleukin-6 were estimated at baseline, 1 and 3 months evaluation periods. Results Significant decrease in pain score was observed in all groups and there was a statistically significant difference between them at all treatment periods in favor to group C. Additionally, all groups showed a decrease in the size of lesions which was greater in group A, C compared to the B group. A significant reduction of the mean interleukin-6 continued down to 3 months in all groups with statistically insignificant difference between them at 3 months, while statistically significant difference in favor to group C at 1 month was observed. Conclusion The results proved the benefit of curcumin as a promising medication when used in combination with conventional therapy in treatment of OLP patients. However, further long-term studies with large sample size are needed. Practical implications To evaluate the therapeutic impact of topically applied curcumin as alternative or complementary to triamcinolone acetonate in treatment of OLP.

Authors

Institutions

Publication Details

Journal
Tanta Dental Journal
Published
2025-01-01
DOI
https://doi.org/10.4103/tdj.tdj_76_24
Citations
1
Primary Topic
Oral Health Pathology and Treatment
Type
article
Field-Weighted Citation Impact
1.47
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The efficacy of topically applied curcumin 1% as alternative or complementary to triamcinolone acetonate in treatment of oral lichen planus (randomized control trial)

Mohamed Fouad, Ahmed Hosny, Rofaida R. Shehata, Shimaa Kotb et al.
1 citations
Tanta Dental Journal
Oral Health Pathology and Treatment
1.47
article

The efficacy of topically applied curcumin 1% as alternative or complementary to triamcinolone acetonate in treatment of oral lichen planus (randomized control trial)

Mohamed Fouad, Ahmed Hosny, Rofaida R. Shehata, Shimaa Kotb, Barra A. El-Din
article en
1 citations

Abstract

Abstract Background Oral lichen planus (OLP) is a chronic inflammatory disorder affecting the mucous membranes, believed to be an immune-mediated condition. Its persisting nature can lead to extended discomfort for those affected. The primary symptoms are pain and a burning sensation, with a potential risk of malignancy if not properly managed, necessitating lifelong clinical monitoring. Presently, OLP is considered a significant challenge due to the absence of a definitive cure. Patients and methods Thirty patients with OLP were divided into three groups, 10 patients each: group A: 10 patients with OLP were received topical triamcinolone acetonide. Group B: 10 patients with OLP were received topical curcumin. Group C: 10 patients with OLP were received topical triamcinolone acetonide combined with topical curcumin for 6 weeks. Each patient was examined at baseline, 1 and 3 months of therapy. Pain was scored using the visual analog scale. Salivary level of interleukin-6 were estimated at baseline, 1 and 3 months evaluation periods. Results Significant decrease in pain score was observed in all groups and there was a statistically significant difference between them at all treatment periods in favor to group C. Additionally, all groups showed a decrease in the size of lesions which was greater in group A, C compared to the B group. A significant reduction of the mean interleukin-6 continued down to 3 months in all groups with statistically insignificant difference between them at 3 months, while statistically significant difference in favor to group C at 1 month was observed. Conclusion The results proved the benefit of curcumin as a promising medication when used in combination with conventional therapy in treatment of OLP patients. However, further long-term studies with large sample size are needed. Practical implications To evaluate the therapeutic impact of topically applied curcumin as alternative or complementary to triamcinolone acetonate in treatment of OLP.

Tanta Dental JournalVol. 22(1)
Al-Azhar University (EG), Assiut University (EG)
Openalex Percentile: Top 19%
Oral Health Pathology and Treatment
1.47
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.